Last update :
16/06/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antibiotic   Meropenem  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Acus Chile, France, Malaysia
Amplium Brazil, Mexico
Anfletec Argentina
Biomerem Venezuela
Klopenem Argentina
Mectinex Chile
Meprim Chile, Ecuador
Merinfec Iceland
Merobac Colombia, Ecuador, Peru
Meromax Brazil, Chile
Meronem Belgium, Brazil, Chile, Colombia, Croatia, Denmark, Ecuador, Egypt, Finland, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Luxembourg, Netherlands, Norway, Peru, Poland, Portugal, Romania, Saudi Arabia, Slovenia, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates
Meropen
Merozan Turkey
Merrem Australia, Canada, France, Italy, Mexico, New Zealand, United States of America
Optinem Austria
Stability of mixtures   injection   Stability of mixtures : Meropenem     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
37°C
10 Hour
Not specified 4180
Level of evidence B
Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
4°C
168 Hour
Not specified 4180
Level of evidence B
Polyvinyl chloride Dianéal® PD2 4.25% glucose (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
37°C
10 Hour
Not specified 4180
Level of evidence B
Polyvinyl chloride Dianéal® PD2 4.25% glucose (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
4°C
168 Hour
Not specified 4180
Level of evidence B
Polyvinyl chloride Dianéal® PD2 2.5% glucose (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
37°C
10 Hour
Not specified 4180
Level of evidence B
Polyvinyl chloride Dianéal® PD2 2.5% glucose (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
4°C
168 Hour
Not specified 4180
Level of evidence B
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
37°C
10 Hour
Not specified 4180
Level of evidence B
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
injection   Meropenem   
injection   Heparin sodium 0,5 UI/ml
4°C
168 Hour
Not specified 4180
Level of evidence B
Polypropylene Sodium chloride 0,9% 4 mg/ml
injection   Meropenem   
injection   Tedizolid phosphate 0.8 mg/ml
-25 >> -15°C
8 Day
Protect from light 4405
Level of evidence B
Polypropylene Sodium chloride 0,9% 4 mg/ml
injection   Meropenem   
injection   Tedizolid phosphate 0.8 mg/ml
2-8°C
6 Day
Protect from light 4405
Level of evidence B
Polypropylene Sodium chloride 0,9% 4 mg/ml
injection   Meropenem   
injection   Tedizolid phosphate 0.8 mg/ml
25°C
12 Hour
Protect from light 4405
Level of evidence B
  Mentions Légales